Summary
A study was conducted to investigate changes in monoamine metabolism in the brain of rats with acute ischemic hepatic failure (AHF) induced by two-stage hepatic devascularization. Strict artificial cardiopulmonary management was used to exclude possible confounding effects of hypotension, hypothermia and hypoxemia that often appear in AHF. Rats were put in an incubator at 34°C before the ligation of the hepatic artery (second stage operation), tracheotomized and ventilated artificially throughout the remaining experimental periods. No significant difference was observed in physiological parameters, including body temperature, pulse rate and systolic arterial blood pressure or PaO2 between AHF and sham operated rats. Brain levels of norepinephrine (NE) and its metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG), dopamine (DA) and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanilic acid (HVA), and serotonin (5-hydroxytryptamine, 5HT) and its metabolite 5-hydroxyindoleacetic acid (5HIAA) were determined by HPLC-voltametry. AHF rats showed significantly higher MHPG, DOPAC, 5HIAA and lower NE levels in the brain compared to controls. In addition, a significant negative correlation between NE and tyrosine (Tyr), a significant positive correlation between MHPG and Tyr or phenylalanine (Phe), and a significant positive correlation between DOPAC and Tyr or Phe were observed. In conclusion, the changes in monoamine metabolism in the brain of AHF rats are clearly induced specifically by hepatic failure itself, possibly through an altered metabolism of amino acids.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fischer JE, Baldessarini RJ: False neurotransmitters and hepatic failure. Lancet II 1971;2:75–80.
Funovics JM, Fischer JE: Brain energy metabolism and alterations of transmitter profiles in acute hepatic coma. J Neural Transmission 1978;14(Suppl):61–67.
Hashimoto O, Saito K, Kobatake M, et al: Clinical and experimental studies on brain serotonin metabolism in hepatic encephalopathy. Acta Hepat Jap 1980;21:693–703. (in Japanese)
Hashimoto O: Experimental studies on abnormal brain serotonin metabolism in hepatic encephalopathy (II)—Effect of administration of Fischer’s amino acids solution (GO-80). Acta Sch Med Univ Gifu 1980;28:613–628. (in Japanese)
Saito K: Studies on abnormal metabolism of brain monoamines in hepatic encephalopathy (I)—Abnormal metabolism of brain catecholamines and its restoration by administration of special amino acids preparation. Acta Sch Med Univ Gifu 1981;29:1310–1324. (in Japanese)
Saito K: Studies on abnormal metabolism of brain monoamines in hepatic encephalopathy (II)—The effects of administration of LDOPA on abnormal metabolism of brain monoamines in rats with ischemic hepatic failure. Acta Sch Med Univ Gifu 1981;29:1325–1342. (in Japanese)
Kato T, Saito K, Murakami N, et al: Studies on abnormal metabolism of norepinephrine in the brain of rats with hepatic failure. Acta Hepat Jap 1990;31:160–171. (in Japanese)
Degos F, Degos JD, Bourdiau D, et al: Experimental acute hepatic encephalopathy: comparison of the electroencephalograpahic changes in the liverless and in the eviscerated rat. Clin Sci Mol Med 1974;47:599–608.
Livingstone AS, Potvin M, Goresky CA, et al: Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology 1977;73:697–704.
Traver P, Dalcanto M, Ganger D, et al: Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization. Gastroenterology 1989;96:885–891.
Murakami M, Kato T, Saito K, et al: Preliminary study on abnormal metabolism of monoamines in the brain of rats with acute hepatic failure—Under cardiopulmonary management. Acta Hepat Jap 1989;30(Suppl. 1):158 (abstr). (in Japanese)
Silverstein F, Johnston MV: Effects of hypoxia-ischemia on monoamine metabolism in the immature brain. Ann Neurol 1984;15:342–347.
Okuda C, Saito A, Miyazaki M, et al: Alteration of the turnover of dopamine and 5-hydroxytryptamine in rat brain associated with hypothermia. Pharmacol Biochem Behav 1986;24:79–83.
Olson EB Jr: Separate effects of low carbon dioxide and low oxygen content on rat brain monoamine metabolism during hypoxemia. Life Sci 1988;42:1469–1476.
Kobatake M: Study on relationship between plasma and brain amino acids in various animal models of hepatic failure. Acta Sch Med Univ Gifu 1981;29:870–908. (in Japanese)
Furukawa K, Karasawa T, Kadokawa T: An HPLC-ECD analysis of free and conjugated forms of biogenic monoamines and their metabolites in biological samples. Jpn J Pharmacol 1986;40 (Suppl):149 (abstr).
Sato N: Doubutsu zikken no kihon. 1st ed. Niigata: Nishimura Shoten. 1986;253. (in Japanese)
Trewby PN, Williams R: Pathophysiology of hypotension in patients with fulminant hepatic failure. Gut 1977;18:1021–1026.
Tomita E: Clinico-pathological study on two clinical types of fulminant hepatitis—An analysis of fifty four cases. Acta Sch Med Univ Gifu 1981;29:1032–1070. (in Japanese)
Bihari DJ, Gimson AES, Williams R: Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis 1986;6:119–128.
Ida Y: Age-related changes in brain noradrenaline metabolism at steady or stressed state in rats. J Kurume Med Assoc 1981;44:932–948. (in Japanese)
Kopin IJ: Catecholamine metabolism: Basic aspects and clinical significance. Pharmacol Rev 1985;37:334–364.
Stone EA: Accumulation and metabolism of norepinephrine in rat hypothalamus after exhaustive stress. J Neurochem 1973;21:589–601.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murakami, N., Saito, K., Kato, T. et al. Changes in brain monoamine metabolism in rats with acute ischemic hepatic failure under artificial cardiopulmonary management. Gastroenterol Jpn 27, 191–198 (1992). https://doi.org/10.1007/BF02777722
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02777722